申请人:Epple Robert
公开号:US20100022592A1
公开(公告)日:2010-01-28
The invention provides compounds of formula (IA) or (IB) and pharmaceutical compositions thereof, which are useful for modulating G protein-coupled receptor 120 (GPR120), and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated GPR120.
本发明提供公式(IA)或(IB)的化合物及其制药组合物,这些化合物对调节G蛋白偶联受体120(GPR120)有用,并且使用这些化合物的方法用于治疗、改善或预防与异常或失调的GPR120相关的疾病。